Results 151 to 160 of about 63,738 (185)

End‐organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure‐2 (RELAX‐AHF‐2)

European Journal of Heart Failure, EarlyView.
End‐organ protective effect of serelaxin in patients with acute heart failure. CV, cardiovascular; HF, heart failure; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Abstract Aims Serelaxin is recombinant human relaxin‐2, a hormone responsible for haemodynamic adaptations and organ protection in pregnancy.
Adriaan A. Voors, Marco Metra, Douwe Postmus, Barry H. Greenberg, Gadi Cotter, Beth A. Davison, Iris E. Beldhuis, G. Michael Felker, Gerasimos Filippatos, Peter S. Pang, Piotr Ponikowski, Claudio Gimpelewicz, John R. Teerlink   +12 more
wiley   +1 more source

The transcriptional profile of iron deficiency in patients with heart failure: Heme‐sparing and reduced immune processes

European Journal of Heart Failure, EarlyView.
The analysis workflow, findings and potential clinical consequences of iron deficiency in heart failure (HF). From 881 patients with worsening HF, whole blood transcriptome was analysed using the Affymetrix Human Transcriptome Array (HTA) 2.0. Subjects were stratified according to their transferrin saturation (TSAT) levels as iron‐deficient (TSAT <20%)
Niels Grote Beverborg, Ridha I.S. Alnuwaysir, George Markousis‐Mavrogenis, Martijn F. Hoes, Haye H. van der Wal, Simon P.R. Romaine, Mintu Nath, Andrea Koekoemoer, John G.F. Cleland, Chim C. Lang, Stefan D. Anker, Kenneth Dickstein, Marco Metra, Leong L. Ng, Dirk J. van Veldhuisen, Adriaan A. Voors, Nilesh J. Samani, Peter van der Meer   +17 more
wiley   +1 more source

Association of a remote monitoring programme with all‐cause mortality and hospitalizations in patients with heart failure: National‐scale, real‐world evidence from a 3‐year propensity score analysis of the TELESAT‐HF study

European Journal of Heart Failure, EarlyView.
Association of a remote monitoring programme (RMP) with all‐cause mortality and hospitalization in heart failure (HF) patients. COPD, chronic obstructive pulmonary oedema; HR, hazard ratio; ICU, intensive care unit; LTI, long‐term illness; RR, rate ratio; SoC, standard of care.
Nicolas Girerd, Vanessa Barbet, Marie‐France Seronde, Hélène Benchimol, Annabelle Jagu, Jean‐Michel Tartière, Olivier Hanon, François Picard, Stéphane Lafitte, Magali Lemaitre, Nicolas Pages, Sophie Nisse‐Durgeat, Patrick Jourdain   +12 more
wiley   +1 more source

Remote patient monitoring in heart failure: A comprehensive meta‐analysis of effective programme components for hospitalization and mortality reduction

European Journal of Heart Failure, EarlyView.
Remote patient monitoring in heart failure (HF). Abstract AimsMethods of non‐invasive remote patient monitoring (RPM) for heart failure (HF) remain diverse. Understanding factors that influence the effectiveness of RPM on HF‐related and all‐cause hospitalizations, mortality, and emergency department visits is crucial for developing successful RPM ...
Ignace L.J. De Lathauwer, Wessel W. Nieuwenhuys, Frederique Hafkamp, Marta Regis, Rutger W.M. Brouwers, Mathias Funk, Hareld M.C. Kemps   +6 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diuretics

British Journal of Hospital Medicine, 2009
Diuretics enhance the rate of excretion of sodium ions (Na+) and water. They are usually taken in the morning so that diuresis does not intrude upon sleep. Diuretics are divided into groups based on their mechanism and site of action: loop, thiazide, potassium-sparing, osmotic, mercurial and carbonic anhydrase inhibitors (Figure 1).
Mah, Baig, R, Shakur, D, Scott
  +8 more sources

Diuretics

2006
Diuretic therapy is generally used to treat edematous states in the cases of renal insufficiency, nephrotic syndrome, liver cirrhosis, and heart failure. Edema is an abnormal accumulation of fluid in the intercellular spaces of connective tissue. Interestingly, there are minor differences in composition of fluid generated with various diseases.
K Sembulingam, Prema Sembulingam
  +5 more sources

Diuretics

Medical Clinics of North America, 1989
Diuretics are a mainstay of modern medical therapy. Their effects on electrolyte excretion can largely be predicted from knowledge of their sites of action along the renal tubule. This article examines the role of diuretics in cardiac and noncardiac disease.
openaire   +2 more sources

Diuretics

AACN Advanced Critical Care, 1992
Diuretics are the mainstay of therapies for many diseases, including hypertension congestive heart failure. While their use can be beneficial, many side effects and interactions are attributed to diuretic therapy. This chapter reviews the mechanism of action for the various diuretics and elucidates differences between classes.
openaire   +2 more sources

Diuretics and Pregnancy

Scandinavian Journal of Clinical and Laboratory Investigation, 1984
(1984). Diuretics and Pregnancy. Scandinavian Journal of Clinical and Laboratory Investigation: Vol. 44, No. sup169, pp. 83-85.
openaire   +4 more sources

Excretion and diuretic action of mercurial diuretics

Experientia, 1957
Huit diuretiques mercuriels ont ete etudies selon la technique deSperber utilisant la circulation porte renale de la poule. Six d'entre eux ont montres clairement leur elimination par secretion tubulaire. Une diurese acqueuse peut etre obtenue avec tous les diuretiques etudies, dans la plupart des cas elle est unilaterale du cote injecte.
openaire   +3 more sources